India's Strides Pharma up 8% after unit gets FDA nod
** Shares of Strides Pharma Science SRID.NS rise as much as 7.7% to 537.30
Indian rupees as at 10:15 a.m. IST
** Stock hits highest since Sept. 15
** Pharma's Singapore unit receives approval for medication for
cardiovascular diseases from the U.S. Food and Drug Administration urn:newsml:reuters.com:*:nBSE7VPXZ7
** Nearly 1.1 mln shares change hands, 1.8 times their 30-day moving avg of
630,322 shares
** As of YTD, stock had risen 48.1%
(Reporting by Archishma Iyer in Bengaluru)
((Archishma.Iyer@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees